The first treatment for an inherited immune system disorder first identified in 2013 will be made available to patients in England, it has been announced.
Leniolisib will be available for patients over the age of 12 with activated phosphoinositide...
7 months ago
Scientists have unveiled a “next generation” CAR-T therapy, aimed at treatment-resistant cancers.
Developers in Colorado, USA, say their “supercharged” version of CAR-T will enhance the effectiveness and longevity of the therapeutic cells. It is d...
7 months ago
